Viewing Study NCT04890392


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-01-28 @ 6:26 PM
Study NCT ID: NCT04890392
Status: UNKNOWN
Last Update Posted: 2021-08-12
First Post: 2021-04-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Gastric Cancer View
None Advanced Gastroesophageal Junction Adenocarcinoma View
Keywords: